MedPath

Self-screening of Cardiovascular Risk

Not Applicable
Completed
Conditions
Risk Factor, Cardiovascular
Interventions
Behavioral: CV-screening-2 plus personalized
Behavioral: CV-screening-2 plus standard
Behavioral: CV-screening-1 plus standard
Behavioral: CV-screening-1 plus personalized
Registration Number
NCT02373319
Lead Sponsor
Parc de Salut Mar
Brief Summary

The aims of this study are (1) to validate a self-screening method for cardiovascular (CV) risk that does not require the supervision of a health professional (including self-measurement of blood pressure, lipid profile evaluated by dry chemistry, and self-administered questionnaires on sex, age, diabetes, and tobacco consumption). (2) From these data, the investigators will generate personalized recommendations based on the best available evidence. The investigators will also analyze whether this innovative approach improves adherence to preventive recommendations for cardiovascular and other chronic diseases.

Detailed Description

Primary prevention activities based on some admittedly blunt screening instruments such as cardiovascular (CV) risk functions must be addressed to the whole population, prioritizing certain sectors of the population. However, the main limitation of current risk screening procedures is related to the natural history of cardiovascular disease, whose expression depends on the cumulative exposure to cardiovascular risk factors throughout a person's lifetime. Early prevention of cardiovascular disease is key to reduce this cumulative risk, thereby reducing the incidence of cardiovascular events.

The objectives of this study are (1) to validate a self-screening method for cardiovascular risk that does not require the supervision of a health professional (including self-measurement of blood pressure, lipid profile evaluated by dry chemistry, and self-administered questionnaires on sex, age, diabetes, and tobacco consumption). (2) From these data, the investigators will generate personalized recommendations based on the best available evidence. The investigators will also analyze whether this innovative approach improves adherence to preventive recommendations for cardiovascular and other chronic diseases.

Cardiovascular risk measured with the self-screening method will be compared with the gold standard (cardiovascular risk supervised by health professional). Participants will be randomly assigned to the intervention (communication of cardiovascular risk and recommendation of personalized preventive actions) or control groups (communication of cardiovascular risk). Subjects will be reexamined one year after recruitment for assessing adherence to the preventive recommendations in terms of improvement in the control of cardiovascular risk factors.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
960
Inclusion Criteria
  • Understand and accept the study's procedures and sign an informed consent form
  • Inhabitants of Girona (Gerona, Spain) and the metropolitan area
Exclusion Criteria
  • History of cardiovascular disease
  • Individuals with terminal disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
CV-screening-2 plus personalizedCV-screening-2 plus personalizedSelf-screening of cardiovascular risk - 15 minutes wash-out - Cardiovascular risk screening supervised by health professional; Communication of personalized recommendations according to the health exam results for the control of cardiovascular risk factors
CV-screening-2 plus standardCV-screening-2 plus standardSelf-screening of cardiovascular risk - 15 minutes wash-out - Cardiovascular risk screening supervised by health professional; Standard communication of the health exam results
CV-screening-1 plus standardCV-screening-1 plus standardCardiovascular risk screening supervised by health professional - 15 minutes wash-out - Self-screening of cardiovascular risk; Standard communication of the health exam results
CV-screening-1 plus personalizedCV-screening-1 plus personalizedCardiovascular risk screening supervised by health professional - 15 minutes wash-out - Self-screening of cardiovascular risk; Communication of personalized recommendations according to the health exam results for the control of cardiovascular risk factors
Primary Outcome Measures
NameTimeMethod
Pre-post changes in blood lipid levels[Time frame: From baseline to 12 months after the intervention]

Pre-post changes in mean levels of blood lipid levels (total, HDL and LDL cholesterol). Blood samples will be obtained at baseline and 12 months after the intervention.

Secondary Outcome Measures
NameTimeMethod
Pre-post changes in body mass indexFrom baseline to 12 months after the intervention

Pre-post changes in mean levels of systolic and diastolic blood pressure. Measures will be obtained at baseline and 12 months after the intervention.

Pre-post changes in controlled blood lipid levelsFrom baseline to 12 months after the intervention

Pre-post changes in the percentage of individuals with controlled blood lipid levels according to the most updated European Clinical Practice Guidelines (total, HDL and LDL cholesterol). Blood samples will be obtained at baseline and 12 months after the intervention.

Pre-post changes in controlled body mass indexFrom baseline to 12 months after the intervention

Pre-post changes in the percentage of individuals with body mass index below 25 kg/m2. Measures will be obtained at baseline and 12 months after the intervention.

Mean difference between two methods of cardiovascular risk estimationFrom baseline to 30 minutes

Comparison of cardiovascular risk estimates by two methods (Screening of cardiovascular risk supervised by health professional (Gold Standard) - self-screening of cardiovascular risk). Measures with each method will be taken 30 minutes apart after a wash-out period

Pre-post changes in controlled blood pressureFrom baseline to 12 months after the intervention

Pre-post changes in the percentage of individuals with controlled systolic and diastolic blood pressure levels (140 and 90 mmHg, respectively). Measures will be obtained at baseline and 12 months after the intervention

Pre-post differences in smoking statusFrom baseline to 12 months after the intervention

Pre-post changes in the percentage of smokers. Smoking status will be assessed at baseline and 12 months after the intervention

Pre-post changes in blood pressureFrom baseline to 12 months after the intervention

Pre-post changes in mean levels of systolic and diastolic blood pressure. Measures will be obtained at baseline and 12 months after the intervention.

Trial Locations

Locations (1)

Unitat de Suport a la Recerca de Girona IDIAP Jordi Gol

🇪🇸

Girona, Spain

© Copyright 2025. All Rights Reserved by MedPath